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Human gene therapyr virus (MMTV) is a type B retrovirus that is unique from other retroviruses in
having multiple “tissue speciﬁc” and “hormone inducible” promoters. This unique feature has lead to the
increasing interest in studying the biology of MMTV replication with the ultimate goal of developing MMTV
based vectors for potentially targeted human gene therapy. In this report, we describe, for the ﬁrst time, the
establishment of an in vivo genetic complementation assay to study various aspects of MMTV replication. In
the assay described here, the function of MMTV Rem/RmRE regulatory pathway has been successfully
substituted by a heterologous retroviral constitutive transport element (CTE) from Mason Pﬁzer Monkey
Virus (MPMV) for mature MMTV particle production. Our results revealed that in the absence of MPMV CTE
or Rem/RmRE, RNA transcribed from MMTV Gag-Pol expression plasmids were efﬁciently transported to the
cytoplasm. However, the presence of CTE was indispensable for Gag-Pol protein expression. In addition, we
report the development of MMTV based vectors in which the packageable RNA was transcribed either from
MMTV LTR or from a chimeric LTR, which could successfully be packaged and propagated by particles
produced from MMTV Gag-Pol expression plasmids containing a heterologous transport element. The role of
MPMV CTE in the transport of MMTV transfer vector RNA was not found to be signiﬁcant. Development of
such an assay should not only shed light on howMMTV regulates its gene expression, but also should provide
additional molecular tools for delineating the packaging determinants for MMTV, which is imperative for the
development of novel vectors for targeted and inducible gene therapy.
© 2008 Elsevier Inc. All rights reserved.Introduction
The mouse mammary tumor virus (MMTV) is a type B retrovirus,
which causes breast cancer and T cell lymphomas in mice (reviewed in
Mustafa et al., 2000, 2003). Historically, MMTV has been classiﬁed as a
simple retrovirus, a retrovirus that contains only the structural genes
necessary for virus particle formation (gag/env) and those coding for
enzymes required for virus replication (pro/pol) (Cofﬁn,1992). However,
it has long been known thatMMTV also encodes additional viral factors,
sag (superantigen) (Acha-Orbea and Palmer, 1991; Marrack et al., 1991)
and perhaps Naf (Salmons et al., 1990). Like other complex retroviruses
such as human, simian, and feline immunodeﬁciency viruses (HIV, SIV,
and FIV, respectively) in which Rev responsive element (RRE) interacts
with Rev protein, MMTV Rem-Responsive Element (RmRE) present at
the 3′ end of the genome interactswith Rem (Indik et al., 2005;Mertz et
al., 2005; Müllner et al., 2008) as well as with HIV-1 Rev (Dangerﬁeldmunology, Queen's University,
SATS Institute of Information
l rights reserved.et al., 2005). Because of the presence of these accessory genes and
regulatory elements, it has recently been suggested that MMTV be
classiﬁed as a complex murine retrovirus (Mertz et al., 2005).
In addition,MMTV is distinct frommostother retroviruses in another
aspect in that it maintains multiple promoters for the expression of its
various genes (Arroyo et al., 1997; Günzburg et al., 1993; Miller et al.,
1992); two promoters in the LTR and possibly two in the env reading
frame (reviewed in Mustafa et al., 2000). Compared to that, a virus as
complex as HIV, encoding at least ten genes, contains only one standard
promoter in the LTR for its transcriptional needs. This makes MMTV
more similar to the only other known retrovirus shown to contain an
additional promoter in the env gene, the foamy virus (Meiering et al.,
2001). MMTV promoters in the LTR are unique because they are
inducible by steroid hormones due to the presence of hormone
responsive elements (HREs) within the U3 region of the LTR, which
contribute to these inducing effects (Ham et al., 1988). Because of these
distinctive characteristics, MMTV LTR promoters have beenwidely used
for transgene expression in the mouse model of human breast cancer
(Ahmed et al., 2002; Andrechek et al., 2003; Ross and Solter, 1985;
Stewart et al., 1984; Wagner et al., 1997), thus making them major
candidate promoters to be used in human breast cancer gene transfer
studies. The side effects associated with the conventional cancer
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approaches such as gene therapy or gene-directed enzyme prodrug
therapy (GDEPT). In GDEPT, a drug-metabolizing transgene is selectively
delivered into tumor cells where its “conditional” and “targeted”
expression is under the inﬂuence of an inducible promoter, which can
be controlled by providing the inducing agent. This aspect alone had
prompted the use of MMTV promoters for “conditional” and “targeted”
geneexpression in gene therapyandGDEPT. Inone such study, retroviral
vectors containing MMTV LTR promoters have been used allowing the
elevated transgene expression in both human and non-human cell lines
that could be further improved by inductionwith dexamethasone (Klein
et al., 2008). Therefore, the inducible and tissue-speciﬁc control of
MMTV promoters make them valuable tools for the study of gene
expression and the development of novel MMTV based vectors for
targeted human gene therapy.
Before MMTV based vectors can be exploited for human gene
therapy, it is important that the pertinent aspects of MMTV replication
are understood. One of the hallmarks and very essential step of
retroviral life cycle is the efﬁcient and speciﬁc packaging of retroviral
genomic RNA by the assembling virion particles. Very little is known
about the packaging determinants of MMTV that allow the speciﬁc
and preferential packaging of the genomic RNA into the virus particles
over the cellular and other viral RNAs. Only one study exists and
suggests that, like other retroviruses, the 5′end of the MMTV genome
may contain some sequences responsible for RNA packaging (Salmons
et al., 1989). In an attempt to study MMTV replication and RNA
packaging, we report the establishment of a three plasmid trans
complementation assay for MMTV similar to the assays that we and
others have developed to study RNA packaging in other retroviruses
such as HIV, SIV, FIV and MPMV (Naldini et al., 1996; Rizvi and
Panganiban, 1993; Browning et al., 2001).Fig. 1.MMTV gag/pol gene expression is mediated byMPMV CTE. (A) Schematic representatio
without MPMV CTE. (D) Western blot analysis of transfected 293T cell lysates with MMTV G
shown by arrows. As a control for protein loading, the same blot was stripped and reprobed w
as a control. (E) Transfection efﬁciencies were measured by luciferase activity from the co-tra
microgram protein.Brieﬂy, in this assay, retroviral cis and trans-acting factors are
separated into three individual plasmids. Two plasmids provide gag/
pol and env structural and regulatory genes, whereas a third plasmid
called transfer vector contains the minimal cis-acting sequences
needed for RNA packaging, reverse transcription, and integration as
well as a marker gene that allows monitoring the vector propagation
into the target cells. Due to the presence of the packaging signal only
in the transfer vector, its RNA serves as the only source for the
packagable RNA into the virus particles produced by Gag-Pol
expression plasmids. The three plasmids are co-transfected into the
producer cells resulting in the generation of virus particles containing
the packaged transfer vector RNA that is capable of transducing the
gene of interest into the target cells, the replication of which is limited
to a single round with no further chance of reinfection.
Results and discussion
MPMV constitutive transport element (CTE) can substitute the function
of Rem/RmRE nuclear export pathway
As a ﬁrst step towards establishing MMTV trans complementation
assay, we had to develop MMTV Gag-Pol expression plasmid capable
of producing virus particles that can package and propagate MMTV
transfer vector RNAs. It has recently been shown that the expression of
MMTV Gag-Pol proteins from an unspliced genomic message is
dependent on the presence of Rem/RmRE export pathway and that
MMTV RNA can interact with the HIV-1 Rev protein to upregulate its
gene expression (Dangerﬁeld et al., 2005; Indik et al., 2005; Mertz et
al., 2005; Müllner et al., 2008). Our goal was to develop a Gag-Pol
expression vector in which Rem/RmRE sequences are eliminated to
reduce the chances of recombination between the same elementsn of a complete MMTV genome. (B and C) MMTV Gag-Pol expression plasmids with and
ag-Pol expression plasmids. Both processed and unprocessed forms of Gag protein are
ith antibodies against β-actin. Cellular lysate frommock transfected 293T cells is shown
nsfected pGL3 control DNA using the Dual Luciferase Assay kit RLU, relative light units/
Fig. 2. Role ofMPMV CTE in the transport of MMTV gag/pol RNA. (A) Cytoplasmic (A.1) and
nuclear fractions (A.2) were isolated from the transfected 293T cells and DNase treated
RNAswere ampliﬁedusingMMTVGag speciﬁc primersOTR567 andOTR552 to ruleout the
possibility of any contaminating plasmidDNAs from the transfected cultures (B) PCRof the
cytoplasmic (B.1) and nuclear (B.2) cDNAs ampliﬁed using MMTV Gag speciﬁc primers
described above,whichwill amplify 400 bp region of Gag. PCRswere conducted for 20, 25,
and 30 cycles. (C) Control for nucleocytoplasmic fractionation technique. To demonstrate
that the integrity of the nuclear membrane was maintained during nucleocytoplasmic
fractionation, cytoplasmic RNA fractions were tested for the presence of unspliced β-actin
mRNA,which is foundexclusively in thenuclear fractions. C.1 shows thepresenceof spliced
β-actin mRNA in the cytoplasmic fraction. C.2 shows the multiplex RT-PCR of cytoplasmic
RNA fraction for unsplicedβ-actinmRNA that should be exclusively nuclear, thus could not
be detectedwith 25 cycles of PCR. C.3 showsmultiplex RT-PCR for unsplicedβ-actinmRNA
in nuclear RNA fraction. (−) C and (+) C represents negative and positive controls,
respectively; (⁎) denotes a sample that was lost.
466 T.A. Rizvi et al. / Virology 385 (2009) 464–472among the packaging constructs and the transfer vectors. Since it has
already been shown that the MPMV constitutive transport element
(CTE) can compensate for the Rev/RRE regulatory system in case of
HIV and SIV (Bray et al., 1994; Rizvi et al., 1996), we tested whether the
MPMV CTE could substitute for the function of Rem/RmRE export
pathway in the case of MMTV. Therefore, a region encompassing
MMTV gag/pol genes was cloned in either the absence or presence of
MPMVCTE into expression plasmids (Figs.1B and C). DesigningMMTV
Gag-Pol expression plasmids in such a fashion, which at the 5′end
lacked region spanning R and most of U5 and at the 3′ end lacked all
the sequences from nucleotide 7147 till the end of HYB MTV, removed
most of the cis-acting sequences needed for packaging, reverse
transcription, and integration. Therefore, the RNA expressed from
these Gag-Pol expression plasmids can only express the viral
structural proteins, however cannot be packaged and propagated by
the assembling virus particles. Such an assumption was based on an
earlier report of Salmons et al., in which replacing the 5′LTR of MMTV
with that of Rous sarcoma virus (RSV) resulted in abolishing MMTV
RNA packaging (Salmons et al., 1989). Such a design of the packaging
construct, which removed most of the cis-acting elements, should
diminish the possibility of recombination between the packaging
construct and transfer vectors, which may result in generating
replication competent virus.
Co-transfection of these Gag-Pol expression plasmids along with a
control plasmid, pGL3 DNA, expressing ﬁreﬂy luciferase for transfec-
tion efﬁciencies (Ghazawi et al., 2006), demonstrated the successful
expression of MMTV Gag-Pol proteins only in the presence of MPMV
CTE (Fig. 1D). This was despite the fact that the transfection
efﬁciencies for these expression plasmids (with and without CTE)
were within two folds (Fig. 1E). Next, we wanted to investigate what
may have contributed to the inability of the CTE (−) vectors to express
Gag-Pol proteins. Towards this end, we fractionated the RNA obtained
from the transfected 293T cells into cytoplasmic and nuclear fractions
to assess whether the CTE (−) gag/pol RNAs were efﬁciently
transported from the nucleus to the cytoplasm. As a ﬁrst step, both
nuclear and cytoplasmic fractions were DNase treated and PCR
ampliﬁed using MMTV Gag speciﬁc primers (OTR567/OTR552) in
order to ascertain that the RNA preparations were devoid of any
contaminating plasmid DNA, whichmay compound the interpretation
of our results. Fig. 2A.1 and A.2 show that both nuclear and
cytoplasmic RNA preparations were free of any contaminating
plasmid DNA. Having conﬁrmed this, we conducted RT-PCR for 20,
25, and 30 cycles on the cDNAs prepared from both CTE (−) and CTE (+)
cytoplasmic and nuclear RNA fractions using MMTV Gag primers
(OTR567/OTR552) to evaluate the effect of the presence or absence of
CTE on the transport of these RNAs. RT-PCR analysis revealed that both
CTE (−) and CTE (+) MMTV gag/pol RNAwere efﬁciently transported to
the cytoplasm (Fig. 2B), however the proteins were expressed only by
the CTE (+) RNAs (Fig. 1D). These results were rather surprising since
the presence of CTE has largely been implicated in the efﬁcient
transport of unspliced messages of both cellular and viral genes
(reviewed in Felber et al., 2007). Because of these unexpected results,
we wanted to ensure that there was no artifact in our fractionation
technique resulting in the damage of the nuclear membrane, which
may have contributed to the leakage of RNAs transcribed fromGag-Pol
expression plasmids from the nucleus to the cytoplasm. To rule out
such a possibility, cytoplasmic RNA fractions were tested by RT-PCR
for the presence of unspliced β-actin mRNA, which is found
exclusively in the nuclear fraction unless the integrity of the nuclear
membrane has been compromised during the fractionation process
(Tan et al., 1995). Since we were looking for the lack of unspliced β-
actin message, it was imperative for us to ensure that this lack of
unspliced β-actin message in the cytoplasmic fraction was not due to
the lack of ampliﬁable cDNAs in PCR reactions. Therefore, the RT-PCR
was performed for 25 cycles as a multiplex in the presence of primers/
competimers for 18S ribosomal RNA as an ancillary control. The resultsof the RT-PCR show that spliced β-actin messagewas observed only in
the cytoplasmic fraction (Fig. 2C.1). On the other hand, unspliced β-
actin message was undetectable (Fig. 2C.2) even though it could be
detected in the nuclear fractions (Fig. 2C.3). Ampliﬁcation of 18S
ribosomal RNA in multiplex PCR conﬁrmed the presence of ampliﬁ-
able cDNA. Taken together, these results suggest that no compromise
was made on the integrity of the nuclear membrane during the
fractionation process, thus it is reasonable to conclude that the MMTV
gag/pol mRNAs were efﬁciently transported even in the absence of
CTE. Therefore, the efﬁcient MMTV gag/pol gene expression by the CTE
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suggest that perhaps there are other underlying mechanisms, which
regulates gene expression following RNA transport.
Two recent reports have shown that MMTV unspliced gag/pol
genomic message is dependent on Rem/RmRE pathway and any
perturbations in this pathway result in the inefﬁcient transport of gag/
polmessage, consequently resulting in the lack of gag gene expression.
One of these studies was conducted in the wild type virus by mutating
the Rem protein (Mertz et al., 2005), while the other one was
conducted in the presence of the entire viral sequences (expressed
via cytomegalovirus (CMV) promoter and polyadenylated by bovine
growth hormone (BGH) poly A) by introducing deletions in the RmRE
(Müllner et al., 2008). On the other hand, the sub-genomicMMTVGag-
Pol expression plasmids described in this study contained limited viral
sequences, apart from the gag/pol sequences, and therefore the lack of
other viral sequences in these expression plasmids may have
contributed in part in their efﬁcient transport even in the absence of
CTE. Consistent with this possibility, in contrast to other retroviruses,
the RNA transport of MMTV sub-genomic expression plasmids
containing only envelope cDNA was not found to be inﬂuenced by
Rem/RmRE pathway (Müllner et al., 2008). It is therefore reasonable to
hypothesize that the additional sequences present on the unspliced
RNA in the two recently published studies (Mertz et al., 2005; Müllner
et al., 2008) may have synergistically contributed along with the gag/
pol sequences in entrapping gag/pol message in the nucleus. It would
therefore be interesting to investigate how much sequences, other
than the gag/pol in the sub-genomic context, would be needed to
disrupt the RNA transport in the absence of CTE, if at all.
Several earlier and recent studies, including ours, have used sub-
genomic HIV, SIV, and FIV Gag-Pol expression plasmids, however,Fig. 3. Role of MPMV CTE in MMTV transfer vector RNA transport and packaging. (A) Schemat
for 20 and 25 cycles using MMTV speciﬁc primers (OTR 463 and OTR 676), which would am
MMTV U3 region (Upper panel). The lower panel represents DNase-treated cytoplasmic RNA
contaminating plasmid DNA from the transfected cells; + C, plasmid as a positive control
ampliﬁcation of cytoplasmic cDNAs and hybridized using a probe fromMMTV U3 region. PCR
viral RNAs were also treated with DNase and ampliﬁed using MMTV speciﬁc primers to co
positive control. (D) Control for nucleocytoplasmic fractionation technique as described in
unspliced β-actin mRNA that should be exclusively nuclear. The spliced β-actin mRNAwas p
could not be detected with 25 cycles of PCR (upper panel); however it could be detected inmajority of these expression plasmids have included sequences such
as RRE, MPMV CTE, or cellular CTE, and at times contained β-globin
intron (Bray et al., 1994; Rizvi et al., 1996; Browning et al., 2001; Bor
et al., 2006; Swartz et al., 2007). When post-transcriptional
regulatory elements replaced Rev/RRE function in these expression
plasmids, protein expression was measured and was found to be
efﬁciently expressed. It is therefore plausible to speculate that the
gag/pol RNA from these sub-genomic expression plasmids may
have been efﬁciently transported even in the absence of post-
transcriptional regulatory elements if they contained only limited
viral sequences other than the gag/pol sequences. Along the same
line, Butsch et al. have analyzed the nucleocytoplasmic transport of
unspliced HIV-1 gag/pol RNA and Gag protein production from sub-
genomic expression plasmids with or without a post-transcriptional
regulatory element from spleen necrosis virus (SNV) (Butsch et al.,
1999). In the absence of any export element they still observed the
transport of HIV-1 gag/pol unspliced RNA, however, the inclusion of
SNV transcriptional regulatory element only modestly increased (2
folds) the cytoplasmic accumulation of unspliced RNA in sharp
contrast to a signiﬁcant increase in Gag protein expression (81,000
pico grams compared to no detectable Gag). The modest increase in
the RNA transport in their observations cannot be sufﬁcient to
account for such a signiﬁcant increase in Gag production in the
presence of SNV post-transcriptional regulatory element. Thus, it is
reasonable to suggest that the inclusion of MPMV CTE in MMTV
Gag-Pol expression plasmids augmented MMTV Gag-Pol protein
expression by enhancing the translation of MMTV gag/pol RNAs as
has recently been proposed for the translation of unspliced mRNA
containing MPMV CTE (Bor et al., 2006; Jin et al., 2003; Swartz et al.,
2007).ic representation of MMTV transfer vectors. (B) PCR of the cytoplasmic cDNAs ampliﬁed
plify 560 bp region of 3′end of transfer vector RNA and hybridized using a probe from
s, which were ampliﬁed using MMTV speciﬁc primers to eliminate the possibility of any
. (C) PCR of the viral cDNAs ampliﬁed using the same viral speciﬁc primers used for
was performed for 30 cycles (Upper panel). As mentioned earlier for cytoplasmic RNAs,
nﬁrm the absence of any contaminating plasmid DNA (Lower panel); + C, plasmid as a
Fig. 2C and Materials and methods. The upper panel shows the multiplex RT-PCR for
resent in the cytoplasmic fraction (bottom panel), while the unspliced β-actin message
the nuclear fraction used as a control (Upper panel, last lane).
Table 1
Propagation of MMTV transfer vector RNAs in the presence or absence of MPMV CTE
Transfer
vector
Description of the
transfer vector
Marker
gene
Titers
(CFU/ml±SD)a,b
% EGFP
positive
cellsc
DA007 Wild type MMTV
LTR+400 bp Gag
Hygromycin 47±4 –
DA024 Chimeric MMTV
LTR+400 bp Gag+CTE
Hygromycin 1530±41 –
DA025 Chimeric MMTV LTR
+400 bp Gag
Hygromycin 714±8 –
SS008 Wild type MMTV
LTR+400 bp Gag +CTE
EGFP – 0.2
SS013 Chimeric MMTV
LTR+400 bp Gag+CTE
EGFP – 18.5
SS014 Chimeric MMTV
LTR+400 bp Gag
EGFP – 8.9
Mock No DNA (control) – ≤1 ≤1
a CFU/ml, colony forming units per ml of non-concentrated supernatant from the
transfected cultures. SD, standard deviation.
b Each value represents a mean of three experiments performed in duplicates.
c EGFP positive cells represents the phenotypic analysis of the transduced target cells.
Single cell suspension of the infected HeLa CD4+ cells were prepared and 10,000 cells
per group were counted and analyzed using Becton Dickinson FACS.
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protein expression from the CTE (−) RNAs reﬂects their inability to be
translated efﬁciently and suggest that there are further links between
the efﬁciently transported MMTV gag/pol RNA and its translation in
the presence of MPMV CTE indicating complexities in post-transcrip-
tional gene regulation. Thus, it is conceivable to suggest that the
MMTV Gag-Pol protein expression by CTE containing RNAs may have
been facilitated by enhancing polyribosome association of these RNAs
as has recently been shown for HIV-1 gag/pol CTE containing RNA
using splicing regulatory SR protein, 9G8 using 293T cells (Swartz et
al., 2007). The results presented here successfully demonstrate that
MMTV Rem/RmRE regulatory pathway for the expression of gag/pol
genes in a sub-genomic context could be substituted with MPMV CTE,
which interacts with cellular factors thereby obviating the need of any
virally encoded factors to be provided in cis or trans. In addition, the
use of heterologous transport element such as MPMV CTE should also
minimize the chances of recombination with similar sequences
present on the transfer vectors, thus making the trans complementa-
tion assay safer.
Role of MPMV CTE in the transport and packaging of MMTV transfer
vector RNAs
To determine whether the particles produced by MMTV Gag-Pol
expression plasmids containing the MPMV CTE are biologically
relevant and capable of encapsidating and propagating MMTV
transfer vector RNA, a series of MMTV transfer vectors were generated
(Fig. 3A). DA007 is a transfer vector based on HYB MTV molecular
clone (Shackleford and Varmus, 1988) and contains the sequences at
the 5′end up to 400 bp of Gag, a region, which has been broadly
implicated in augmenting RNA packaging in a number of retroviruses
(reviewed in D'Souza and Summers, 2005; Darlix, 1986). At the 3′ end,
it includes sequences from nucleotides 7484 until the end of the 3′LTR
and therefore does not contain the newly identiﬁed Rem protein (Fig.
3A). In addition, it contains hygromycin B phosphotransferase gene
expressed from the simian virus 40 (SV 40) promoter (SV-hygr) as a
marker to monitor vector RNA propagation in the target cells.
We used the three plasmids trans complementation assay to
determine MMTV transfer vector RNA packaging and propagation
potentials. Towards this end, the MMTV transfer vector (DA007) and
the MMTV Gag-Pol expression plasmid containing MPMV CTE (JA10)
were co-transfected along with a vesicular stomatitis virus envelope
protein G (VSV-G) expression construct, MD.G (Naldini et al., 1996)
into 293T producer cells and the transfected cultures were dex-
amethasone induced as described previously (Salmons et al., 1989).
Supernatants containing virus particles were harvested 72 h post-
transfection and used without concentration to infect human HeLa
CD4+ cells and to isolate virion RNA. Transfected 293T cells were
fractionated into nuclear and cytoplasmic RNA fractions to determine
the successful transport of the transfer vector RNA, while whole cell
protein extracts were isolated to determine transfection efﬁciencies.
Infected cultures were selected with medium containing hygromycin
B to identify successfully transduced cells by the appearance of
hygromycin resistance (Hygr) colonies.
The expression of transfer vector (DA007) RNA, its transport from
the nucleus to the cytoplasm, and its ability to be packaged into virus
particles were analyzed by RT-PCR. These analyses revealed that
DA007 RNAwas either poorly expressed or inefﬁciently transported to
the cytoplasm (Fig. 3B) and consequently was packaged at a reduced
level into the virus particles (Fig. 3C). Consistent with the RNA
packaging results, the propagation of DA007 RNA was also poor
(Table 1). These results could be explained on the basis that DA007 did
not contain either MPMV CTE or an intact Rem/RmRE regulatory
system to facilitate the nuclear export of the transfer vector RNA.
Therefore, we generated another transfer vector (SS008), which is
similar to DA007 except that hygromycin gene has been replaced withenhanced green ﬂuorescence protein (EGFP) gene and MPMV CTE was
cloned downstream of the SV-EGFP cassette (Fig. 4A). Vector
propagation in case of SS008 was determined by monitoring EGFP
expression by Fluorescent Activating Cell Sorting (FACS) analysis.
Cloning of MPMV CTE in SS008 did not signiﬁcantly enhance RNA
transport (Fig. 4B) despite high transfection efﬁciency (data not
shown) and therefore continued to show low packaging and
transduction efﬁciencies (Figs. 4C, E, and Table 1). Since the presence
of MPMV CTE in SS008 (when compared to DA007, Figs. 3B and 4B) did
not signiﬁcantly improve RNA transport suggesting that either its
presence is not important in the subgenomic context when only
limited viral sequences are present or the transfer vector RNAs were
not efﬁciently expressed. It is therefore plausible to propose that the
poor expression and consequently poor packaging and propagation in
DA007 and SS008 were due to the poor transcription of these vectors
containing MMTV LTR promoters in human cells.
In order to overcome the potential block of MMTV promoter and to
enhance the expression of the transfer vectors in human cells, the U3
region of the 5′LTR containing the TATAA box was replaced with the
human cytomegalovirus (hCMV) promoter to create a chimeric 5′LTR
in DA007 and SS008, generating DA025 and SS014, respectively. In
DA025 and SS014, the 3′LTR was maintained without any modiﬁca-
tions (Figs. 3A and 4A). To further assess the role of MPMV CTE in
efﬁciently expressed MMTV subgenomic RNAs, we cloned the MPMV
CTE downstream of the SV-hygr cassette in DA025 or SV-EGFP cassette
in SS014, generating DA024 and SS013, respectively (Figs. 3A and 4A).
Following trans complementation, the cytoplasmic RNA fraction from
the transfected cells was isolated and analyzed to monitor vector RNA
expression and transport.
Test of these transfer vector RNAs (DA025, DA024, SS014, and
SS013) revealed that the MMTV transcripts containing the chimeric 5′
LTR were efﬁciently expressed (Figs. 3B and 4B) when compared to
DA007 or SS008, which contained the wild type 5′LTR, suggesting that
the chimeric 5′LTR promoter can overcome the potential block of
MMTV promoter in human cells. Figs. 3B and 4B show that the
presence of CTE in the transfer vector (DA024 and SS013) did not have
pronounced effect on the transport of these RNAs when compared to
the vectors thatwere lacking theMPMVCTE (DA025 and SS014). This is
despite the fact that at least in the case of SS014, which showed lower
transfection efﬁciency when compared to SS013 (data not shown),
transfer vector RNAwas still properly transported (Fig. 4B). Since these
resultswere unexpected, wemade sure that no compromisewasmade
on the integrity of the nuclearmembrane,which could have leaked the
Fig. 4. Role of MPMV CTE in packaging and propagation of MMTV transfer vector RNAs. (A) Schematic representation of MMTV transfer vectors. SS008, SS013, and SS014 are transfer
vectors similar to DA007, DA024 and DA025, respectively, containing EGFP as a marker gene instead of hygromycin. In addition, SS008 contains MPMV CTE when compared to DA007.
(B) PCR of the cytoplasmic cDNAs ampliﬁed using MMTV speciﬁc primers for 20 and 25 cycles as described in Fig. 3B. (C) PCR of the viral cDNAs ampliﬁed using the same viral speciﬁc
primers and probed as described in Fig. 3C. (D) Control for nucleocytoplasmic fractionation technique as described in Fig. 3D. (E) Flow cytometric analysis of the transduced target
cells by FACS. Forty-eight hours post infection, cells were trypsinized, washed with PBS, and ten thousand cells were analyzed for the expression of EGFP from cells that may have
been transduced by MMTV transfer vector RNA containing EGFP gene.
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fractionation process. To ensure this, cytoplasmic RNA fractions were
tested via RT-PCR by detecting the unspliced and spliced β-actin
mRNA. The absence of unspliced β-actin message in the cytoplasmic
RNA fraction (in either the presence or absence of CTE) assured that our
fractionation technique was intact (Figs. 3D and 4D). Therefore, the
transport of the transfer vector RNAwe observedwas bonaﬁde and not
compounded by any technical artifacts.
The packaging of DA024, DA025, SS013, and SS014 into the viral
particles was determined by RT-PCR on the viral RNAs, which
suggested that the presence of CTE did not signiﬁcantly inﬂuence
the packaging of these RNAs (Figs. 3C and 4C) and was in agreement
with the vector RNA transport data (Figs. 3B and 4B). Finally,
propagation of these transfer vector RNAs was determined by
infecting the target cells with virions produced from the transfected
293T cells. Vector propagation was monitored either by selecting the
target cells with media containing hygromycin B in the case of DA025
and DA024 or by monitoring EGFP expression by FACS analysis in the
case of SS014 and SS013. Consistent with the packaging data, these
analyses revealed that the transfer vector RNAs, with or without CTE,
were propagated efﬁciently and were within a range of two folds
(Table 1 and Fig. 4E).
Taken together, these results suggest that while MPMV CTE is
required for the expression of MMTV gag/pol genes, its role in thetransport, expression, and packaging of MMTV transfer vector RNA
was not found to be important. This differential role of MPMV CTE
could possibly be explained on the basis that MPMV CTE is required
when gag/pol sequences are present in totality to overcome the effect
of the putative negative regulatory elements (NREs) within the gag/
pol region. Similar situation has been observed in the case of HIV and
SIV requiring Rev/RRE regulatory system for gag/pol expression, the
function of which could be compensated by MPMV CTE (Bray et al.,
1994; Rizvi et al., 1996). Since our transfer vectors contained only
400 bp of Gag, the putative NREs may not be present in this short
region. As for the LTR sequences in our transfer vectors, it has recently
been shown that MMTV LTR region does not contain cis-acting
repressor or inhibitory sequences requiring a regulatory pathway such
as Rev/RRE for their transport from the nucleus to the cytoplasm
(Dangerﬁeld et al., 2005).
The three plasmids trans complementation assay described here
for MMTV is the ﬁrst demonstration in which MMTV genome has
been separated into two separate plasmids and pseudotyped by an
unrelated viral envelope glycoprotein. So far, successful development
of MMTV Gag-Pol expression plasmids has evaded most investigators
since cloning of MMTV gag/pol sequences have been greatly hampered
due to the presence of inhibitory sequences in the gag gene
(Shackleford and Varmus, 1988) and much was not known about
howMMTV regulates its gene expression. Because of these caveats, to
470 T.A. Rizvi et al. / Virology 385 (2009) 464–472our knowledge, no study so far has been successful in developing
MMTV Gag-Pol expression plasmids capable of producing MMTV
virus particles efﬁciently. Expression plasmids containing MPMV CTE
(JA10- JA12) not only express gag/pol genes, but also the virus particles
produced by them are capable of packaging and propagating the
MMTV RNA in the biologically relevant assay described here. This
trans complementation assay, in which we have separated the ability
to express gag/pol genes from the source of the packageable RNA
should also allow us to mutate the putative MMTV packaging
sequences in the subgenomic viral context, since the packaging
sequences have been shown (for a number of retroviruses) to extend
into gag gene (D'Souza and Summers, 2005; Lever, 2007).
As discussed earlier, the inducible and tissue-speciﬁc control of
MMTV promoters has brought to the limelight the idea of developing
MMTV based vectors for “targeted” and “conditional” gene expression
especially of those genes whose constitutive expression could be toxic
to cells. The present study was undertaken to test the proof of
principle towards developing an in vivo packaging and transduction
assay for MMTV. Some of the vectors described here, for this purpose,
contained the chimeric LTR harboring hCMV promoter to increase the
vector RNA expression in the producer cells and in addition needed an
internal promoter to express the marker genes in target cells.
However, following infection, during the course of reverse transcrip-
tion of the transfer vector RNA, the U3 region of the 3′LTR will be
duplicated and one copy will be transferred to the 5′LTR resulting in
the restoration of the wild type LTR in the integrated provirus. Such a
translocation of the U3 region containing promoter sequences could
bring the expression of the therapeutic gene under the inﬂuence of
the LTR promoter, facilitating its inducible expression, thereby
obviating the need of using an internal promoter for the expression
of the gene of interest. Alternatively, MMTV promoters could replace
SV 40 promoter, used for expressing hygromycin or EGFP genes in our
transfer vectors, for inducible gene expression as has recently been
shown (Klein et al., 2008). The results presented in this study strongly
suggest that MMTV based vectors can transduce genes efﬁciently and
such vectors can be further modiﬁed to be used for in vivo gene
delivery studies. The trans complementation assay described here
should also open new avenues of research towards delineating the
packaging determinants for MMTV in a quantitative fashion, which is
imperative for the development of safe and efﬁcient MMTV based
vectors for potentially “inducible” and “targeted” gene delivery in the
ﬁght against a number of human ailments.
Materials and methods
Plasmid construction
All plasmids described were constructed using the HYB MTV
molecular clone (Shackleford and Varmus, 1988). In order to generate
MMTV Gag-Pol expression constructs, sequences from HYB MTV
containing gag/pol region between BstEII (nt 1277) and HincII (nt
7147) sites were ligated into the EcoRV site of an expression plasmid
containing the pBR322 ori, hCMV promoter, and bovine growth
hormone (BGH) poly A signal. The ligated DNA mixture was
transformed into a number of bacterial strains (JM109, DH5α, STBL-
1, and HB101) to stabilize the clones because most of the transfor-
mants either did not survive or had deletions in the sequences cloned
in the expression plasmid. Out of the several hundred clones screened,
only three clones were successfully identiﬁed from HB101 bacterial
strain, which did not have any deletions in the gag/pol genes and were
named JA07-JA09 (Fig. 1B). Next, a 234 bp DNA fragment with ﬂanking
EcoRV site containingMPMV CTEwas cloned into the blunted NotI site
of JA07-JA09, and the resulting clones containing the CTE in the sense
orientation were named JA10-JA12, respectively (Fig. 1C).
MMTV transfer vectors (Figs. 3A and 4A) were created through
several stages of cloning. Brieﬂy, the 5′ sequences of MMTV genomeup to 400 bp of Gag was ampliﬁed using OTR551 (sense, 5′
gcatcgatAATGCCGCGCCTGCAGCAGA 3′; nucleotides 1–20 of HYB
MTV 5′ U3 region, sequences in lowercase artiﬁcially create a ClaI
site) and OTR552 (antisense, 5′ cgactagtgatatcGTTCCCCTGGTCCCA-
TAAG 3′; nucleotides 1885–1867 of HYB MTV Gag, sequences in
lowercase artiﬁcially create SpeI and EcoRV sites) and HYBMTV as the
template. Using the same template, the MMTV 3′ region was PCR
ampliﬁed using OTR553 (sense, 5′ gcactagtgctagcCCTA-
CATGGTTCTGGGAAAATTCT 3′, nucleotides 7485–7509 of HYB MTV
envelope, sequences in lowercase artiﬁcially create SpeI and NheI
sites) and OTR554 (antisense, 5′ cagggtaccGCTGCCGCAGTCGGCCGACC
3′; nucleotides 9877–9857 of HYB MTV, sequences in lowercase
artiﬁcially create a KpnI site). The resulting 5′end and 3′end PCR
products were digested separately with ClaI/SpeI and SpeI/KpnI,
respectively and ligated to the ClaI and KpnI sites of a pUC derived pIC
(Marsh et al., 1984) based cloning vector, TR277, in a three-way
ligation creating DA001. This was followed by insertion of the SV-hygr
cassette at the artiﬁcially created NheI site of DA001 creating the ﬁnal
clone DA007. To replace theMMTV U3 region containing the promoter
sequences, the R/U5 region up to 400 bp of Gag was ampliﬁed using
OTR617 (sense, 5′ cgcaagcttgagctcGAGTAAACTTGCAACAGTCC 3′;
nucleotides 1163–1182 of HYB MTV 5′end sequences in lowercase
artiﬁcially create HindIII and SacI sites) and OTR552 as the anti-sense
primer. The resulting PCR product was digested with SacI and SpeI and
was ligated along with the SpeI-KpnI fragment from DA001 (contain-
ing the 3′ region of MMTV) to the SacI-KpnI sites of a pcDNA3 based
vector (PP071) in a three way ligation generating an intermediate
clone DA018. Next, SV-hygr-MPMV CTE cassette was inserted at the
artiﬁcially created NheI site of DA018 creating the ﬁnal clone DA024.
DA025 is a transfer vector similar to DA024 and was created by the
insertion of the SV-hygr cassette without CTE at the artiﬁcially created
NheI site of DA018 as described above. Another set of transfer vectors
namely SS008, SS013, and SS014 were generated, which are similar to
DA007, DA024, and DA025, respectively, however contain EGFP as a
marker gene instead of hygromycin. In addition, SS008 differs from
DA007 in another aspect in that it contains MPMV CTE in the presence
of the wild type 5′LTR.
Transfections and infections of cells
The producer 293T cells were used for transfection and the HeLa
CD4+ cellswere used for infection and bothweremaintained at 37 °C in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplementedwith 10%
FBS and 7% calf serum, respectively. Approximately 16 h before the
transfection, 293T cells were seeded in six-well plates at a density of
0.4×106 perwell. Approximately, 2–4 h before transfection,mediawas
changed and the cells were transfected by calcium phosphate method
as described earlier (Mustafa et al., 2005). Brieﬂy, a total of 10 micro-
gram (μg) of DNA (3.3 μg of each plasmid)was used to prepare the DNA
cocktail. As a control for the transfection efﬁciency, 250 ng of theﬁreﬂy
luciferase expression vector pGL3 control (Promega, Madison,WI) was
also introduced in the DNA cocktail. Transfection efﬁciencies in the
cultures were determined by testing a portion of the cells using the
Dual-Luciferase Reporter Assay System (Promega). The luciferase
values obtained were normalized to the protein concentration in the
lysates as determined by the protein assay reagent.
Cells that were transfected with MMTV transfer vectors containing
5′wild type LTR (DA007 and SS008) were induced by 10−6 M
dexamethasone as described previously (Salmons et al., 1989). Virus
released in the supernatants was harvested 72 h post transfection,
cleared of any cell debris, and used to infect HeLa CD4+ cells, which
were plated a day prior to infection at a density of 0.4×106 per 60-
millimeter plate in the presence of DEAE-dextran sulfate as described
previously (Browning et al., 2001). Forty-eight hours post infection,
cells were selected with media containing hygromycin B or trypsinized,
washed with PBS, and analyzed on a Becton Dickinson Fluorescent
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colonies were selected for 10–12 days with media containing hygro-
mycin B, stained with crystal violet dye, and counted as described
previously (Browning et al., 2001).
Ultracentrifugation of virus particles
In order to remove cellular debris, supernatants from tranfected
cultures were centrifuged at 4000 rpm for 10 min. Following which,
viral particles were ﬁltered using 0.2-micron syringe ﬁlters and
pelleted by ultracentrifugation using SW28 rotor at 24,000 rpm for 2 h
at 4 °C. TNE buffer (50 mM Tris–Cl, pH 7.4, 100 mM NaCl, and 1 mM
EDTA, pH 8.0) was used to resuspend the viral pellets to isolate viral
RNA using the Trizol LS reagent.
Nucleocytoplasmic fractionation of transfected cells and RNA isolation
To fractionate RNA into nuclear and cytoplasmic fractions,
transfected cells were taken off from the plates and resuspended in
cold diethylpyrocarbonate (DEPC)-treated RLN buffer (50 mM Tris pH
8, 140 mM NaCl, 1.5 mM MgCl2) supplemented with 0.5 % NP40 and
incubated on ice for 2 min to gently lyse the cells without disrupting
the nuclei. The intact nuclei were spun down at 300 ×g for 2 min and
70% of the cytoplasmic fractions were carefully moved to fresh
eppendorf tubes containing 1 ml Trizol reagent for subsequent RNA
isolation. Nuclear RNA was also isolated from the nuclear pellets by
Trizol method. Pelleted virions in TNE buffer were lysed in 500 μl of
Trizol LS reagent containing 8 μl of polyacryl (used as a carrier) prior to
RNA isolation. Puriﬁed RNA was resuspended in nuclease-free water
and its concentration was determined by spectrophotometry.
Reverse transcriptase polymerase chain reaction (RT-PCR)
To ensure that our RNA preparations were free of any DNA
contamination, 2.5 μg of cytoplasmic and nuclear RNA fractions as well
as one ﬁfth of viral RNAwere DNase treated and reverse transcribed as
described previously (Mustafa et al., 2005). The PCRs for unspliced β-
actin were performed as a multiplex in the presence of primers/
competimers for 18S ribosomal RNA as a control for cDNA addition in
PCR reactions (18S Quantum competimer control, Ambion, Austin,
TX). PCR reactions were performed for varying cycles at various
annealing temperatures depending upon the melting temperature of
the primer set used. To monitor the transport of CTE (−) and CTE (+)
gag/pol RNA, both DNased cytoplasmic and nuclear fractions were
ampliﬁed using MMTV gag speciﬁc primers OTR567 (sense, 5′
ccactagtATGGGGGTCT CGGGCTC 3′; nucleotides 1485–1501 of HYB
MTV Gag, sequences in lowercase represents two dummies bp
followed by SpeI) and OTR552, which would amplify 400 bp region
of Gag. To study vector RNA transport and packaging, both cellular and
viral DNased RNAs as well as cDNAs were ampliﬁed using MMTV
speciﬁc OTR 643 (sense, 5′ cctctagaTGCGAAGAGCCTTGACCAAG 3′;
sequences in lowercase represents 2 dummies bp followed by XbaI
site followed by 8482–8501 nt of MMTV 3′ LTR) and OTR 676
(antisense; 5′ GAGGTTGAGCGTCTCTTTCTATT 3′; nucleotides 9067–
9048 of U3 region of MMTV 3′ LTR), which would amplify 560 bp
region of the transfer vector RNA. Products of PCR were analyzed on
2% agarose gels in the presence of ethidium bromide. Some of the gels
were further processed for Southern blot analysis. Probes for
hybridization were generated by PCR ampliﬁcation using OTR643
and OTR676 and hybridization was performed by using the AlkPhos
Direct Labeling Kit (Amersham, Arlington Heights, IL).
Western blot analysis
For western blot analysis, cellular lysates were prepared from the
293T cells transfected with MMTV Gag-Pol expression plasmids 72 hpost transfection. 200 μg of cellular lysates were used for the detection
of viral protein expression using antibodies speciﬁc for MMTV Gag
protein as described earlier (Mustafa et al., 2000). As a control for
protein loading, the same blot was stripped and reprobed with
antibodies against cellular house keeping gene, β-actin.
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